During the past decade, The Alyce and Elmore Kraemer Cancer Care Center conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 12 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 12 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Alyce and Elmore Kraemer Cancer Care Center" #1 sponsor was "SWOG Cancer Research Network" with 9 trials, followed by "NRG Oncology" with 2 trials sponsored, "NSABP Foundation Inc" with 1 trials sponsored, "National Cancer Institute (NCI)" with 1 trials sponsored and "Radiation Therapy Oncology Group" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Alyce and Elmore Kraemer Cancer Care Center" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator and "Radiation Therapy Oncology Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "The Alyce and Elmore Kraemer Cancer Care Center" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "ATM Gene Mutation" (1 trials), "ATR Gene Mutation" (1 trials) and "Adenosquamous Lung Carcinoma" (1 trials). Many other conditions were trialed in "The Alyce and Elmore Kraemer Cancer Care Center" in a lesser frequency.

Most popular intervention types in "The Alyce and Elmore Kraemer Cancer Care Center" are "Drug" (11 trials), "Other" (9 trials), "Radiation" (5 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (8 trials), "Docetaxel" (4 trials), "Durvalumab" (3 trials), "Carboplatin" (2 trials) and "Cisplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Alyce and Elmore Kraemer Cancer Care Center" are 12 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "The Alyce and Elmore Kraemer Cancer Care Center". undefined are not yet recruiting, undefined are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in The Alyce and Elmore Kraemer Cancer Care Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Alyce and Elmore Kraemer Cancer Care Center, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".